Slide 1A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Notice:
“ statements and conclusions in this presentation reflect personal experience -
are subjective, and may not apply to everyone”
This presentation contains subject matter which may cause extreme pleasure and uncontrollable urges to become an entrepreneur – VIEWER DISCRETION IS ADVISED!
Slide 2A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
-Pharmaceutical industry is growing at a rate of 11.42 % Source :McKinsey Wall street Journal – 7th Jan 2009
-2009 global pharmaceutical sales will be more than $750 billion Source : IMS ORG
Wall Street Journal - 22 hours ago
Slide 3A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
“There are lot many hands behind making previous statement a universal truth and all are acknowledged with time except for few which are constantly contributing to the success of Pharmaceutical Industry but its presence is not felt yet”
Slide 4A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
We are one among them !
Slide 5A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
By: Abhishek Singh2nd Sem MBA(Pharma)
Niper (Mohali)
Animal Healthcare Industry:Niche Market Analysis
Slide 6A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Tide of Presentation
Pharmaceutical human Healthcare market Vs Pharmaceutical animal health care market
Animal health care Market an overviewBusiness trends in the industryForces shaping the futureHidden snap shot of the industryConclusion
Slide 7A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
DisparitiesGlobal Market Value Global Sales of Leading companies Global Sales of Leading Brand Key Findings
Pharmaceutical Human Healthcare Market Vs
Pharmaceutical Animal Healthcare market
Slide 8A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
The global market for human pharmaceuticals isworth 40-times more than its veterinary equivalent.
Sales generated by the world’s leading humanpharmaceutical company are 20-times higher thanthose of the biggest veterinary products business.
There is a 30-fold difference between the researchspending capacity of the market leaders in the twoSectors.
The top-ranked human pharmaceutical companyemploys more research scientists than the world’s20 leading animal health businesses put together.
Disparities:
Slide 9A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Global Market Value
US$(billions)0
100
200
300
400
500
600
700
Human Pharmaceu-tical Source: IMS Health
Veterinary Medicines Source: Wood Mackenzie
Slide 10A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
US$(billions)0
5
10
15
20
25
30
35
40
45
50
Human Pharmaceuti-cal Source: Pfizer
Veterinary Medicines Source: Pfizer
Global sales of leading company
Slide 11A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Global sales of leading brand
US$(billions)0
2
4
6
8
10
12
14
Human Pharmaceuti-cal Source: Pfizer
Veterinary Medicines Source: Merial Merck
Slide 12A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Schering & Plough.doc Wyeth Annual Report.doc Eli Lilly Annual Report.doc Verbec annual report.doc
Key Findings From Balance Sheet of major players
Slide 13A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Animal Healthcare market : An overview
Mapping the vet and pet market Indian Market Product categories Regulatory status
Slide 14A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Structure of World Market by Product Structure of World Market by Species Structure of World Market by Company
Mapping the vet and pet market
Slide 15A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Structure of World Market by Product
Medicinal feed additives ... ...2,150 … .11.2Biological ... . .4,725 … .24.6Anti-infectives ... ... 2,905 … .15.1Parasiticides ... ... 5,450 … .28.4Other pharmaceuticals ... ...3,960 … .20.6
Product Group 2008 share $m
Total 19,190 100.0
Source: Vetnosis Limited (2009)
Slide 16A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Structure of World Market by Species
Cattle ... . .5,135 .26.8Sheep ….. .920 ... ...4.8Pigs ... ...3,135 . .16.3Poultry ... .2,065. .10.8Companion animal / Other .7,935... .41.3
total 19,190 100.0
species 2008 share $m %
Source: Vetnosis Limited (2009)
Slide 17A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Structure of World Market by Company
Animal health market
Rank Companies Sales 2007 Market MUSD share 1 Schering-Plough 2,710 15.1%2 Pfizer 2,639 14.7%3 Merial(*) 2,449 13.7%4 Bayer(1) 1,308 7.3%5 Fort Dodge(#) 1,042 5.8%6 Elanco (eli lilly ltd) 996 5.6%7 Novartis(1) 990 5.5%8 Virbac(1) 600 3.3%9 Boehringer Ingelheim 558 3.1%10 CEVA(1) 460 2.6% (1)excluding non animal health business (*) Merck and Sanofi-Aventis,(#) Animal Health Care Wyeth
Source: Vetnosis, formerly the animal health business of Wood Mackenzie 2007
Pie Chart
Slide 18A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
22%
32%17%
7%
5%10%
7%
Distribution of sales in percentage
France
Rest of Europe
North america
Latin America
Africa & Middle East
Asia
Pacific
Slide 19A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
The total Indian animal health market is approximately Rs 1157 crore Source: Animal Pharm Scrip reports (2006-07)
Poultry sector accounts for a whopping 38% of the animal healthcare market.
Source: Interlink Consultancy
The total exports from India for animal healthcare are INR 188.93
mn. The table below shows the exports of vaccines (in INR mn) in 2005-06 and 2006-07.
Indian Market
Commodity 2005-2006 2006-2007
Vaccines for veterinary medicine 251.26 188.93
Veterinary medicinal preparations 234.87 289.98
Source: Ministry of Commerce, India
Slide 20A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Merger & acquisition GlaxoSmithKline (GSK) Pharmaceuticals sold its animal health business to the French animal-health and veterinary products company Virbac for a consideration of Rs 207.1 crore
Ranbaxy Laboratories divested its allied businesses that included its animal healthcare business to ICICI Venture Funds
Netherlands-based animal nutrition company Provimi acquired the animal health division of Unichem Laboratories.
Nicholas Piramal India Ltd (NPIL) has signed a long-term contract manufacturing agreement with Pfizer International LLC for animal health products.
Wockhardt plans to raise around Rs 150 crore from the sale of the animal healthcare business. Source:7 Apr 2009, 0114 hrs IST, ET Bureau
Charak Pharma is in an advanced stage of negotiation with Swiss multinational Novartis India for a strategic tie-up for the animal healthcare business. Source: Business Standard Thursday, Apr 23, 2009
Pfizer might trim animal health unit to clear Wyeth deal
Slide 21A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Companion Animals
Food Producing Animals
Specialized Products
Product categories
Slide 22A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Companion Animal
Dogs
Equine
Cats
C:\Users\abhisheksingh\Desktop\animal\Bayer Animal Health Products.docx
animal\Products for Dog.docx
animal\Products for Cat.docx
Horses have always been a close companion of humans since historic times
Slide 23A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
A swine and poultry production is an intensive one, most of the medication is given to groups of animals either incorporated in feed or in the drinking water.
Food Producing Animals
Treatments to dairy cattle and grazing animals are individual ones: the mode of application and duration of activity are key drivers of the pharmaceutical development
Cattle, sheep, swine and poultry represent two thirds of the total veterinary market
“If the bee disappeared off the surface of the globe, then man would only have four years left to live. No bees, no pollination, no plants, no animals, no man.” Albert Einstein
Aquaculture is extremely important as it represents the solution to preserve wild fish populations.
animal\Products for Cattle.docx
animal\Product for other livestock.docx
Slide 24A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Specialized Product
Genetic tool helps avoid horned cattle17 Mar 2009 Merial's genetic profiling technology means that herd managers can know for certain the horned status of their cattle when breeding replacements.
Second trial shows cattle E coli O157 vaccine effective18 Mar 2009 Commercial trial shows that Bioniche's Econiche vaccine reduced the colonization of E coli O157 in vaccinated cattle by 92%.
Slide 25A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Regulatory Status
Veterinary Council Of India(A statutory body established under Ministry of Agriculture, Government of India)
Slide 26A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Clutch of drug companies exiting from their animal health businesses, making way instead for dedicated players in the same segment.
Business trends in the industry
Companies have made a big investment in R&D for dogs and cats. Pfizer Animal Health apportioned about $270 million in 2005. Intervet allots 10% of sales to R&D, and Merial spends 6-10% of sales.
Slide 27A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Average development journey for a veterinary product is five to nine years.
Companies that develop drugs for humans need be concerned with only one species when
picking their projects, whereas animal health companies have numerous options.
"Human trials are typically 3,000-10,000 human patients, and animal trials are
maybe 300 animal patients.“
Forces shaping the future
Slide 28A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Combination treatments are another category of product development. Heinen points to a new entry in Bayer's Advantage line of flea products. Advantage Multi is an external, spot application that extends beyond flea control to include, in the same applicator, medicines to prevent heartworm and gastrointestinal nematodes in cats and dogs.
Slide 29A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Advantage was the third best-selling consumer product in Bayer's portfolio, behind only aspirin and a diabetes drughumans have also benefited from drugs originally created for animals e.g Ivermectin(ivermectin as Mectizan to treat humans with onchocerciasis) by Merckviruses and bacteria are species-specific, it is rare to be able to transfer to animals a vaccine that was developed for humans and vice versa. Rabies vaccines are one prominent exception.
Hidden snap shot of the industry
Slide 30A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
"There is huge potential for feline products, but the industry doesn't have a grasp on that because cats are sometimes difficult to deal with," "there are more cats in the U.S. than dogs."
active ingredients responsible for blockbuster human drugs simply need to be reformulated to be ready for animals. Reconcile, nicknamed "puppy Prozac," and some nonsteroidal anti-inflammatory drugs are examples.Researchers also can get unexpected tips from clinical trials of drugs intended for human use. In the case of Pfizer's Slentrol, company researchers were investigating a microsomal triglyceride transfer-protein-inhibitor molecule to treat human atherosclerosis.
Slide 31A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Conclusion
Slide 32A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Slide 33A Free sample background from www.awesomebackgrounds.com
© 2006 By Default!
Top Related